Indegene Limited CC-Sep24.pdf · 2024-10-28
Hi, thanks for the opportunity. A couple of questions from my side. Can you provide an outlook on revenue synergies from the Cult acquisition and the decline in omnichannel activation was related to Cult? And second is what gives you comfort that the digi tization trend in license operations, especially in S&M is continuing to grow at a good pace given that there could have been some normalization post the COVID crisis?
Got it. Very helpful. And one final question from me. How should one look at the revenue decline in Europe, medical devices of India, and ROW? I mean, is this linked to the decline in omni-channel activation and others, is it more of a one-off nature?